Not in the portfolio?
Lipologics develops custom HNOVA™ formulations for actives outside the stock portfolio — from a partner's own compound to a fully licensed programme.
- Co-development and licensing
- Custom particle size and formulation
- Scale-up toward GMP-grade supply
- Confidential, programme-based engagement

